lisuride has been researched along with Adenoma in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (78.95) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R | 1 |
Hashimoto, S; Midorikawa, S; Sanada, H; Watanabe, T; Yatabe, J | 1 |
Kobilková, J; Kucera, E; Marek, J; Srámková, J; Zivný, J | 1 |
Besser, GM; Cookson, JC; Drury, PL; Price, PA; Turner, TH; Wass, JA | 1 |
Borghi, G; Chiodini, P; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Silvestrini, F; Spelta, B; Tonon, C | 1 |
Cerman, J; Golda, V; Látr, I; Rozsíval, V | 1 |
Pospísil, O | 1 |
Benco, R; Crosignani, PG; Dellabonzana, D; Ferrari, C; Liuzzi, A; Mattei, A; Rampini, P; Scarduelli, C; Spelta, B | 1 |
Borghi, PG; Chiodini, PG; Cozzi, R; Horowski, R; Liuzzi, A; Luccarelli, G; Marsili, MT; Passerini, F; Silvestrini, F; Verde, G | 1 |
Bevilacqua, MG; Calderaro, C; Caronti, B; Esposito, V; Gulino, A; Jaffrain-Rea, ML; Palladini, G; Petrangeli, E; Tamburrano, G | 1 |
Angelberger, P; Asenbaum, S; Brücke, T; Czech, T; Deecke, L; Kornhuber, J; Luger, A; Pirker, W; Podreka, I; Riedl, M; Rössler, K | 1 |
Bohnet, HG; Hanker, JP; Horowski, R; Schneider, HP; Wickings, EJ | 1 |
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG | 1 |
Boscaro, M; Mantero, F; Menegus, AM | 1 |
Dorow, R; Gräf, KJ; Horowski, R; Köhler, D | 1 |
Chiodini, P; Cozzi, R; Dallabonzana, D; Dorow, R; Horowski, R; Liuzzi, A; Oppizzi, G; Rainer, E; Verde, G | 1 |
Caselitz, J; Lüdecke, DK; Saeger, W; Schottke, H | 1 |
Pepperell, RJ | 1 |
Chiodini, P; Cozzi, R; Dallabonzana, D; Liuzzi, A; Luccarelli, G; Oppizzi, G; Verde, GG | 1 |
2 review(s) available for lisuride and Adenoma
Article | Year |
---|---|
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2 | 2021 |
Medical treatment of pituitary adenomas: effects on tumor growth.
Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1985 |
17 other study(ies) available for lisuride and Adenoma
Article | Year |
---|---|
Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma.
Topics: Acanthosis Nigricans; Acromegaly; Adenoma; Adult; Bromocriptine; Dopamine Agents; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Lisuride; Magnetic Resonance Imaging; Menstrual Cycle; Ovary; Pancreatic Function Tests; Pituitary Function Tests; Pituitary Neoplasms; Polycystic Ovary Syndrome; Theca Cells | 2003 |
Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
Topics: Adenoma; Adult; Amenorrhea; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced | 1984 |
Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed | 1984 |
[Lisuride in the treatment of hyperfunctioning hypophyseal adenomas].
Topics: Adenoma; Ergolines; Female; Humans; Lisuride; Male; Pituitary Neoplasms; Prolactin | 1983 |
[Lisurid in the treatment of hyperprolactinemia: comments on the article by J. Presl].
Topics: Adenoma; Ergolines; Female; Infertility, Female; Lisuride; Pituitary Neoplasms; Prolactin | 1980 |
Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
Topics: Adenoma; Adolescent; Adult; Amenorrhea; Bromocriptine; Erectile Dysfunction; Ergolines; Female; Galactorrhea; Humans; Lisuride; Male; Metergoline; Middle Aged; Ovarian Function Tests; Pituitary Neoplasms; Pregnancy; Prolactin; Visual Fields | 1982 |
Size reduction of a prolactin secreting adenoma during long-term treatment with the dopamine agonist lisuride.
Topics: Adenoma; Adult; Ergolines; Female; Humans; Lisuride; Pituitary Neoplasms; Prolactin; Sella Turcica; Time Factors; Tomography, X-Ray Computed | 1980 |
Effects of gonadal steroids on the growth of human pituitary adenomas in vitro.
Topics: Adenoma; Adult; Androgens; Bromocriptine; Cell Division; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Hormone Antagonists; Humans; Lisuride; Male; Metribolone; Middle Aged; Pituitary Neoplasms; Progesterone; Prolactin; Receptors, Estrogen; Receptors, Progesterone; Testosterone; Thymidine; Tritium; Tumor Cells, Cultured | 1995 |
Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Benzamides; Bromocriptine; Cerebellum; Corpus Striatum; Cushing Syndrome; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Nelson Syndrome; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1996 |
Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders.
Topics: Adenoma; Administration, Oral; Adult; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Lisuride; Luteinizing Hormone; Menstruation; Menstruation Disturbances; Metoclopramide; Pituitary Neoplasms; Progesterone; Prolactin | 1979 |
Alpha-1 adrenergic blockade: a possible mechanism of action of dopaminergic drugs on ACTH secretion.
Topics: Adenoma; Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Animals; Dopamine; Epinephrine; Ergolines; Female; Humans; In Vitro Techniques; Lisuride; Lypressin; Pituitary Gland, Anterior; Pituitary Neoplasms; Prazosin; Rats; Rats, Inbred Strains | 1985 |
Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride.
Topics: Adenoma; Adult; Ergolines; Female; Follow-Up Studies; Humans; Lisuride; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1986 |
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Menstruation; Middle Aged; Pituitary Neoplasms | 1986 |
Ultrastructural morphometry of prolactin secreting adenomas treated with dopamine agonists.
Topics: Adenoma; Adolescent; Adult; Bromocriptine; Cell Nucleolus; Cell Nucleus; Dopamine; Endoplasmic Reticulum; Ergolines; Ergot Alkaloids; Exocytosis; Female; Humans; Lisuride; Male; Mitochondria; Organoids; Pituitary Neoplasms; Prolactin | 1986 |
Management of prolactinomas. A reappraisal.
Topics: Adenoma; Bromocriptine; Ergolines; Female; Humans; Lisuride; Metergoline; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Radiotherapy Dosage; Radiotherapy, High-Energy; Time Factors | 1985 |
Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
Topics: Adenoma; Adult; Aged; Bromocriptine; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radiography; Receptors, Dopamine | 1985 |